SODIUM SULFACETAMIDE
Producer: CIAO Biofarm Ukraine
Code of automatic telephone exchange: S01A B04
Release form: Liquid dosage forms. Drops are eye.
General characteristics. Structure:
Active ingredient: 1 ml of solution contains 300 mg of Sodium sulfacetamidum;
excipients: sodium metabisulphite, 1M hydroxide sodium solution, water for injections.
Pharmacological properties:
Pharmacodynamics. Antimicrobic means of group of streptocides. Drug is effective at streptococcal, gonococcal, pneumococcal and collibacillary infections. Works bacteriostatically. The mechanism of action is connected with competitive antagonism with para-aminobenzoic acid and competitive oppression of a digidropteroatsintetaza that leads to disturbance of synthesis of the tetrahydrofolic acid necessary for synthesis of purines and pyrimidines.
Pharmacokinetics. At instillation on a conjunctiva the sulfacetamide of sodium gets into the eye environment where makes the specific antibacterial impact. Works preferential locally, but a part of drug is soaked up through the inflamed conjunctiva and gets to a system blood stream.
Indications to use:
Infectious and inflammatory diseases of eyes which are caused by microflora, sensitive to drug (conjunctivitis, a keratitis, blepharites, purulent helcomas, бленнорея). Gonorrheal diseases of eyes at newborns and adults, prevention of a blennorea at newborns.
Route of administration and doses:
Drug is dug in in the affected eye on 1–2 drops of 3-6 times a day. Course of treatment of 7-10 days. At gonorrheal diseases of eyes: topical treatment (in the form of an instillation of 30% solution a sodium sulfacetamide). For prevention of a blennorea at newborns dig in in eyes on the 2nd drop directly after the birth and on the 2nd drop in 2 hours.
Features of use:
At helcomas powder it the crushed powder (powder) a sulfacetamide of sodium of 5-6 times a day to full epithelization, then pass 30% of aqueous solution to an instillation. During pregnancy and feeding by a breast of sufficient experiment on use there is no drug. Use of a sulfacetamide of sodium for treatment of pregnant women is possible and during a lactation on doctor's orders if the expected medical effect exceeds risk of development of possible side effects.
Side effects:
The taking place burning in eyes, reddening of a conjunctiva.
Interaction with other medicines:
At combined use with novocaine, Dicainum, anaesthesin the bacteriostatic effect decreases; dipheninum, salicylates increase toxicity of a sulfacetamide of sodium; at use from antikoagulyana of indirect action specific activity of the last increases. The sodium sulfacetamide at topical administration is incompatible with silver salts.
Contraindications:
Hypersensitivity to components of drug and other streptocides.
Overdose:
Symptoms. Considerable irritation of a mucous membrane of an eye.
Treatment: in these cases immediately stop administration of drug. In case of need appoint symptomatic therapy.
Storage conditions:
To store in the place protected from light, at a temperature from 8 °Сдо 15 °C. A period of storage – 2 years. After opening of a bottle – 20 days.
Issue conditions:
According to the recipe
Packaging:
On 5 or 10 ml of 30 % of solution in a bottle.